Free Trial
NASDAQ:BGLC

BioNexus Gene Lab (BGLC) Stock Price, News & Analysis

BioNexus Gene Lab logo
$2.87 -0.02 (-0.69%)
As of 04/24/2025 04:00 PM Eastern

About BioNexus Gene Lab Stock (NASDAQ:BGLC)

Key Stats

Today's Range
$2.77
$2.99
50-Day Range
$2.17
$3.69
52-Week Range
$2.01
$8.40
Volume
37,270 shs
Average Volume
266,331 shs
Market Capitalization
$5.16 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

BioNexus Gene Lab Corp., through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers. Its products are used to produce handrails, bench tops, automotive and aero parts, and paneling for hospital, laboratory, industrial clean rooms, and covers for various instruments used in manufacturing. The company also involves in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers to detect potential risk of diseases. It markets its products through its website, warehouse, marketing personnel, and suppliers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.

BioNexus Gene Lab Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
5th Percentile Overall Score

BGLC MarketRank™: 

BioNexus Gene Lab scored higher than 5% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for BioNexus Gene Lab.

  • Percentage of Shares Shorted

    6.47% of the float of BioNexus Gene Lab has been sold short.
  • Short Interest Ratio / Days to Cover

    BioNexus Gene Lab has a short interest ratio ("days to cover") of 1.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in BioNexus Gene Lab has recently decreased by 50.17%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    BioNexus Gene Lab does not currently pay a dividend.

  • Dividend Growth

    BioNexus Gene Lab does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    6.47% of the float of BioNexus Gene Lab has been sold short.
  • Short Interest Ratio / Days to Cover

    BioNexus Gene Lab has a short interest ratio ("days to cover") of 1.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in BioNexus Gene Lab has recently decreased by 50.17%, indicating that investor sentiment is improving significantly.
  • Search Interest

    2 people have searched for BGLC on MarketBeat in the last 30 days.
  • MarketBeat Follows

    1 people have added BioNexus Gene Lab to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, BioNexus Gene Lab insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.70% of the stock of BioNexus Gene Lab is held by insiders.

  • Percentage Held by Institutions

    Only 18.85% of the stock of BioNexus Gene Lab is held by institutions.

  • Read more about BioNexus Gene Lab's insider trading history.
Receive BGLC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioNexus Gene Lab and its competitors with MarketBeat's FREE daily newsletter.

BGLC Stock News Headlines

New “Trump” currency proposed in DC
According to one of the most connected men in Washington… A surprising new bill was just introduced in Washington. Its purpose: to put Donald Trump’s face on the $100 note. All to celebrate a new “golden age” for America.
BioNexus Gene Lab enacts reverse stock split
BioNexus Gene Lab Corp trading halted, news pending
Bionexus Gene Lab enters partnership with ML Tech
See More Headlines

BGLC Stock Analysis - Frequently Asked Questions

BioNexus Gene Lab's stock was trading at $2.7970 at the beginning of the year. Since then, BGLC shares have increased by 2.6% and is now trading at $2.87.
View the best growth stocks for 2025 here
.

Shares of BioNexus Gene Lab reverse split on Monday, April 7th 2025. The 1-10 reverse split was announced on Saturday, January 1st 2000. The number of shares owned by shareholders was adjusted after the market closes on Sunday, April 6th 2025. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

BioNexus Gene Lab (BGLC) raised $5 million in an IPO on Thursday, July 20th 2023. The company issued 1,300,000 shares at $4.00 per share. Network 1 Financial Securities acted as the underwriter for the IPO.

Shares of BGLC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that BioNexus Gene Lab investors own include Sangamo Therapeutics (SGMO), NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Adobe (ADBE), Arista Networks (ANET) and e.l.f. Beauty (ELF).

Company Calendar

Today
4/25/2025
Next Earnings (Estimated)
5/21/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical laboratories
Sub-Industry
Healthcare
Current Symbol
NASDAQ:BGLC
Fax
N/A
Employees
30
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-2,630,000.00
Pretax Margin
-9.93%

Debt

Sales & Book Value

Annual Sales
$9.51 million
Price / Cash Flow
N/A
Book Value
$0.55 per share
Price / Book
5.22

Miscellaneous

Free Float
17,605,000
Market Cap
$5.16 million
Optionable
Not Optionable
Beta
5.41
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:BGLC) was last updated on 4/25/2025 by MarketBeat.com Staff
From Our Partners